adelmidrol has been researched along with 2,4-dinitrofluorobenzene sulfonic acid in 1 studies
| Studies (adelmidrol) | Trials (adelmidrol) | Recent Studies (post-2010) (adelmidrol) | Studies (2,4-dinitrofluorobenzene sulfonic acid) | Trials (2,4-dinitrofluorobenzene sulfonic acid) | Recent Studies (post-2010) (2,4-dinitrofluorobenzene sulfonic acid) |
|---|---|---|---|---|---|
| 14 | 1 | 12 | 115 | 0 | 59 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Gugliandolo, E; Impellizzeri, D; Siracusa, R | 1 |
1 other study(ies) available for adelmidrol and 2,4-dinitrofluorobenzene sulfonic acid
| Article | Year |
|---|---|
Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Topics: Amides; Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Colitis; Cyclooxygenase 2; Cytokines; Dicarboxylic Acids; Dinitrofluorobenzene; Ethanolamines; Extracellular Signal-Regulated MAP Kinases; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Mice; NF-kappa B; P-Selectin; Palmitic Acids; Peroxidase; Phosphorylation; PPAR alpha; PPAR gamma; Receptor, Cannabinoid, CB2; Signal Transduction; Tyrosine | 2016 |